Understanding how diabetes-related genetic variants affect pancreatic cell stress responses
Dissecting the roles of type 2 diabetes-associated variants and effector genes in islet endoplasmic reticulum stress response
This study is looking at how certain genes linked to type 2 diabetes affect the way pancreatic cells handle stress, which could help us find new ways to treat diabetes and improve health for people living with it.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11037969 on NIH RePORTER |
What this research studies
This research investigates the impact of genetic variants associated with type 2 diabetes on the stress responses of pancreatic islet cells. By analyzing how these variants influence gene expression and regulatory elements during endoplasmic reticulum stress, the study aims to uncover mechanisms that contribute to pancreatic cell dysfunction. The approach includes advanced genomic techniques to assess chromatin accessibility and gene activity in response to stress. Patients may benefit from insights that could lead to new therapeutic strategies for managing diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 2 diabetes or those at high genetic risk for developing the condition.
Not a fit: Patients without type 2 diabetes or those with other unrelated metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for type 2 diabetes by identifying new targets for therapy.
How similar studies have performed: Previous research has shown that genetic variants can significantly influence disease mechanisms, suggesting that this approach has potential for success.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Bhuiyan, Redwan — University of Connecticut Sch of Med/dnt
- Study coordinator: Bhuiyan, Redwan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.